Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims
Overview
Authors
Affiliations
A major initiative of the Quantitative Imaging Biomarker Alliance is to develop standards-based documents called "Profiles," which describe one or more technical performance claims for a given imaging modality. The term "actor" denotes any entity (device, software, or person) whose performance must meet certain specifications for the claim to be met. The objective of this paper is to present the statistical issues in testing actors' conformance with the specifications. In particular, we present the general rationale and interpretation of the claims, the minimum requirements for testing whether an actor achieves the performance requirements, the study designs used for testing conformity, and the statistical analysis plan. We use three examples to illustrate the process: apparent diffusion coefficient in solid tumors measured by MRI, change in Perc 15 as a biomarker for the progression of emphysema, and percent change in solid tumor volume by computed tomography as a biomarker for lung cancer progression.
Arita Y, Kwee T, Akin O, Shigeta K, Paudyal R, Roest C Insights Imaging. 2025; 16(1):7.
PMID: 39747744 PMC: 11695553. DOI: 10.1186/s13244-024-01884-5.
Shiroishi M, Erickson B, Hu L, Barboriak D, Becerra L, Bell L Radiology. 2024; 313(3):e232555.
PMID: 39656118 PMC: 11694077. DOI: 10.1148/radiol.232555.
Hu H, Chen H, Hernando D MAGMA. 2024; 37(4):551-563.
PMID: 38349454 PMC: 11428149. DOI: 10.1007/s10334-024-01148-9.
MRI biomarkers in neuro-oncology.
Smits M Nat Rev Neurol. 2021; 17(8):486-500.
PMID: 34149051 DOI: 10.1038/s41582-021-00510-y.
Transformational Role of Medical Imaging in (Radiation) Oncology.
Coolens C, Gwilliam M, Alcaide-Leon P, de Freitas Faria I, Moraes F Cancers (Basel). 2021; 13(11).
PMID: 34070984 PMC: 8197089. DOI: 10.3390/cancers13112557.